 Improvement cadaver renal transplantation outcomes verapamil review cyclosporin CsA substantial advances organ transplantation due immunosuppressive properties use direct nephrotoxic effects Initial studies mice CsA dose-related inhibition subcapsular microcirculation subsequent clinical investigations inhibitory effect Efforts CsA-induced nephrotoxicity calcium antagonists example calcium antagonist verapamil initiation CsA renal blood flow Verapamil therapy rejection episodes weeks transplantation CsA therapy current study mg renal artery surgery mg days regimen delayed function incidents need dialysis first post-transplant week kidneys technical failures graft losses secondary patients verapamil beneficial effects verapamil therapy transplant outcome ability cells ischemia selective vasodilation efferent arteriole CsA blood levels inherent immunosuppressive properties